Regional Manager
About the job
- Strictly implement company compliance policies and ensure promotional activities are lawful and compliant.
- Collaborate effectively with internal departments, including Marketing and Medical, to implement market strategies accurately in the region and allocate resources effectively.
- Develop and break down regional business objectives and action plans based on the company’s overall strategy and the characteristics of the Zhejiang regional market, and lead the team to meet or exceed business targets.
- Manage the daily work of the Zhejiang regional business team, including regional managers and medical representatives; recruit, train, and develop the talent pipeline. Improve the team’s professional promotion capabilities and compliance awareness through joint customer visits and performance coaching.
- Establish macro- and micro-level market analysis systems; monitor national and Zhejiang medical insurance policies, volume-based procurement developments, and industry trends. Monitor competitor activity, adjust regional competitive strategies, and identify market growth opportunities.
- Develop and maintain relationships with regional key opinion leaders, major hospitals, and key decision-makers; build academic exchange platforms and increase the company’s academic influence and brand recognition in the region.
About the company
Sanofi is a global pharmaceutical and biotechnology company that develops, manufactures, and sells prescription medicines, over-the-counter products, and vaccines. Its products span immunology, oncology, rare diseases, and vaccines, addressing unmet medical needs through a strong focus on research and development. Sanofi's core product model relies on large-scale R&D, strategic partnerships, and licensing to bring new therapies to markets, with revenue generated from product sales and collaborations. The company differentiates itself by leveraging its global reach, diverse portfolio, and emphasis on patient-centric solutions, safety, and quality to navigate regulatory environments in developed and emerging markets. The company’s goal is to improve health outcomes and quality of life for people worldwide by delivering innovative treatments and vaccines that meet unmet medical needs.
Company Size
10,001+
Company Stage
IPO
Headquarters
Paris, France
Founded
1973
Get referred to Sanofi
See people who can refer or advise you
Simplify's Take
What believers are saying
- July 10, 2026 FDA approval of Sarclisa Escena created the first on-body cancer injector.
- June 13, 2026 FDA accelerated approval expanded Tzield into recently diagnosed stage 3 T1D.
- Q2 2026 sales grew 17.8% at CER, with Dupixent and Beyfortus leading.
What critics are saying
- Texas sued Sanofi on February 19, 2026 over provider bribery and Medicaid fraud.
- Sanofi sued Pfizer and Moderna on July 15, 2026, extending costly mRNA patent warfare.
- Dupixent concentration makes 2030s patent loss an existential revenue shock.
What makes Sanofi unique
- Dupixent reached €5.2 billion quarterly sales in Q2 2026 across nine indications.
- October 1, 2026, Sanofi and Regeneron added four long-acting antibodies to their Alliance.
- Sanofi's 61-project pipeline spans immunology, rare diseases, vaccines, neurology, and oncology.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Health Insurance
- Professional Development Budget
- Parental Leave